Please provide your email address to receive an email when new articles are posted on . ATLANTA — Treatment with repeat doses of rituximab is superior to daily azathioprine for preventing relapse ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have the potential to prevent ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. The MUSC research team, led by ...

John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

A large meta-analysis sheds light on the best antipsychotic maintenance strategy to prevent relapse in clinically-stable schizophrenia — with some unexpected results that have potential implications ...

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the ...

Major depressive disorder or what is more commonly known as clinical depression is a significant condition that can impact many aspects of people’s lives. It causes prolonged and persistent symptoms ...

A new study suggests wrist-worn sleep trackers may help predict depression relapse weeks early—explore what this means for ...

Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. With funding from the National ...